Health ❯ Healthcare

Clinical Trials

Drug Development Phase 3 Trials Drug Efficacy Patient Outcomes Phase III Trials Research Studies Randomized Controlled Trials Efficacy Studies Cancer Research Drug Approval

21 ARTICLES

11h ago

Pig Kidney Kept Patient Off Dialysis for 271 Days and Was Replaced by Human Donor Kidney

The Lancet case shows engineered porcine kidneys can serve as a temporary bridge to allotransplantation but leaves unanswered questions about late vascular injury and long-term safety.

8 ARTICLES

11h ago

Psilocybin Prevents Chemotherapy Nerve Damage in Mice

7 ARTICLES

12h ago

GLP‑1 Prescriptions for 8–11‑Year‑Olds Jump 310‑Fold, NYU Study Finds

4 ARTICLES

17h ago

FDA Approves Zanvastro as First Treatment for Alexander Disease

Stories older than 24h

9 ARTICLES

yesterday

FDA Clears Pancreatic Drug That Shows Early Promise in RAS‑Mutant Lung Cancer

3 ARTICLES

yesterday

AbbVie Completes $10.9 Billion Buy of Apogee Therapeutics

4 ARTICLES

yesterday

Thyme Care Raises Over $125M and Creates Thyme Companies to Tackle Gaps in Cancer Care

8 ARTICLES

2d ago

Plozasiran Cuts Triglycerides About 80% and Greatly Lowers Pancreatitis Risk in Phase III Trials

4 ARTICLES

5d ago

Moderna and Merck Report Phase 3 Success for Personalized mRNA Melanoma Vaccine

9 ARTICLES

5d ago

FDA Approves First Broad RAS Inhibitor for Metastatic Pancreatic Cancer

6 ARTICLES

6d ago

Atorvastatin Cuts Major Cardiovascular Events by 30% in Adults 70 and Older

3 ARTICLES

6d ago

Registry-Based Digital Outreach Doubles Use of SGLT2 Drugs in Heart Failure Trial

3 ARTICLES

6d ago

Edoxaban Shows No Net Benefit for Atrial Fibrillation Patients After Intracranial Haemorrhage

4 ARTICLES

6d ago

Milvexian Fails to Cut Heart Attack, Stroke or Death After Acute Coronary Syndrome

10 ARTICLES

6d ago

FDA Approves Mounjaro to Lower Heart‑Attack and Stroke Risk in High‑Risk Type 2 Diabetes

Clinical Trials

Pig Kidney Kept Patient Off Dialysis for 271 Days and Was Replaced by Human Donor Kidney

Psilocybin Prevents Chemotherapy Nerve Damage in Mice

GLP‑1 Prescriptions for 8–11‑Year‑Olds Jump 310‑Fold, NYU Study Finds

FDA Approves Zanvastro as First Treatment for Alexander Disease

FDA Clears Pancreatic Drug That Shows Early Promise in RAS‑Mutant Lung Cancer

AbbVie Completes $10.9 Billion Buy of Apogee Therapeutics

Thyme Care Raises Over $125M and Creates Thyme Companies to Tackle Gaps in Cancer Care

Lilly to Buy Merida Biosciences for Up to $2.875 Billion

Penn Launches Phase I Trial of ConformalFLASH Proton Therapy

Novartis Pauses CAR‑T Autoimmune Trials After Three Deaths

Never miss stories about

Clinical Trials

FDA Expands Mounjaro Label to Include Cardiovascular Risk Reduction

FDA Approves Rusfertide (Mimrylo) for Polycythemia Vera

Plozasiran Cuts Triglycerides About 80% and Greatly Lowers Pancreatitis Risk in Phase III Trials

Moderna and Merck Report Phase 3 Success for Personalized mRNA Melanoma Vaccine

FDA Approves First Broad RAS Inhibitor for Metastatic Pancreatic Cancer

Atorvastatin Cuts Major Cardiovascular Events by 30% in Adults 70 and Older

Registry-Based Digital Outreach Doubles Use of SGLT2 Drugs in Heart Failure Trial

Edoxaban Shows No Net Benefit for Atrial Fibrillation Patients After Intracranial Haemorrhage

Milvexian Fails to Cut Heart Attack, Stroke or Death After Acute Coronary Syndrome

FDA Approves Mounjaro to Lower Heart‑Attack and Stroke Risk in High‑Risk Type 2 Diabetes

Never miss stories about

Clinical Trials